The Chemours Company (CC)
| Market Cap | 4.45B |
| Revenue (ttm) | 4.98B |
| Net Income (ttm) | -117.00M |
| Shares Out | 164.24M |
| EPS (ttm) | -0.72 |
| PE Ratio | n/a |
| Forward PE | 10.52 |
| Dividend | $1.00 |
| Dividend Yield | 3.73% |
| Trading Day | January 26 |
| Last Price | $26.79 |
| Previous Close | $27.03 |
| Change ($) | -0.24 |
| Change (%) | -0.89% |
| Day's Open | 27.18 |
| Day's Range | 26.51 - 27.30 |
| Day's Volume | 979,077 |
| 52-Week Range | 6.94 - 28.70 |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...
DuPont de Nemours Inc. , Corteva Inc. and Chemours Co. announced Friday an agreement to settle legal disputes, and to establish a cost-sharing arrangement related to PFAS liabilities. Under te...
WILMINGTON, Del., Jan. 22, 2021 /PRNewswire/ -- DuPont de Nemours, Inc. (NYSE: DD), Corteva, Inc. (NYSE: CTVA) and The Chemours Company (NYSE: CC) today announced they have entered into a bind...
WILMINGTON, Del., Jan. 21, 2021 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Titanium Technologies, a...
Is (CC) Outperforming Other Basic Materials Stocks This Year?
Expectations about stimulus package, Fed's supportive stance, and vaccine rollout have helped investors remain optimistic, which calls for investing in growth stocks like D.R. Horton (DHI) and...
Chemours (CC) possesses solid growth attributes, which could help it handily outperform the market.
Does Chemours (CC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...
Chemours (CC) gains on a recovery in demand from the coronavirus-induced slowdown, strong execution and its cost-reduction measures.
Investors target stocks that have been on a bullish run, lately. Stocks seeing price strength have higher chances of carrying the momentum ahead.
The chemical industry has recovered from the pandemic-led slump and looks set for an upturn this year on a rebound in end-market demand. CBT, HUN, CC, PPG and CE to gain from the industry's re...
WILMINGTON, Del., Jan. 5, 2021 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Fluoroproducts and...
A rebound in China, demand upturn across major markets and recovering manufacturing activities augur well for the chemical industry heading into 2021.
4 Diversified Chemical Stocks Set to Ride the Industry's Upturn
Chemours (CC) benefits from demand recovery, cost-management initiatives and strong execution.
Let's see if The Chemours Company (CC) stock is a good choice for value-oriented investors right now from multiple angles.
The U.S. chemical industry is poised for an upturn next year on a rebound across major end-markets and a recovery in chemical exports.
Does Chemours (CC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Chemours (CC) gains on a recovery in demand from the coronavirus-induced slowdown and its cost-reduction measures.
CC has received multiple upward earnings revisions from analysts over the past month. CC has very attractive 10% - 12% options yields, which are detailed at the end of this article.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...
Chemours (CC) reported earnings 30 days ago. What's next for the stock?
A rebound in demand across major end markets has put the wind back in the sails of the chemical industry.
Chemours (CC) benefits from demand recovery across its markets and its cost-cutting actions.
Chemours Will Benefit From Biden Climate Spending: CEO
Nov.30 -- Chemours Chief Executive Officer Mark Vergnano discusses debt reduction efforts, acquisition strategy, and global growth outlook with Bloomberg's Ed Hammond on "Bloomberg Markets: Th...
Chemours (CC) to use the net proceeds along with cash on hand to finance the purchase price as well as unpaid and accrued interest of senior notes due 2023.
WILMINGTON, Del., Nov. 27, 2020 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and...
WILMINGTON, Del., Nov. 25, 2020 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and...
Does Chemours (CC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Chemours (CC) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...
Chemours (CC) to employ the net proceeds along with cash on hand to fund the purchase price as well as unpaid and accrued interest of senior notes due 2023.
WILMINGTON, Del., Nov. 12, 2020 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and...
Chemicals company The Chemours Co. said Thursday it is offering $750 million of senior notes in a private offering, joining the many companies raising record levels of capital during the pande...
WILMINGTON, Del., Nov. 12, 2020 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and...
WILMINGTON, Del., Nov. 12, 2020 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and...
Chemours (CC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
The Chemours Company (CC) CEO Mark Vergnano on Q3 2020 Results - Earnings Call Transcript
The shares of The Chemours Company (NYSE:CC) are up 1% at $21.98 at last check, after the chemical company reported better-than-anticipated third-quarter earnings, as well as revenue just abov...
Lower volumes and prices hurt sales across Chemours' (CC) Fluoroproducts and Chemical Solutions segments in Q3.
Chemours (CC) delivered earnings and revenue surprises of 46.88% and 5.20%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
WILMINGTON, Del., Nov. 3, 2020 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and Ti...
Miller Value Partners recently released its Q3 2020 Investor Letter, a copy of which you can download here. In the third quarter, the Miller Income Strategy fund returned 7.89% versus 4.71% fo...
WILMINGTON, Del., Oct. 28, 2020 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts an...
WILMINGTON, Del., Oct. 14, 2020 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in fluoroproducts, titanium technologies, a...
WILMINGTON, Del., Sept. 30, 2020 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in fluoroproducts, titanium technologies, ...
WILMINGTON, Del., Sept. 8, 2020 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts an...
Chemours (CC) reported earnings 30 days ago. What's next for the stock?
About CC
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Fluoroproducts, Chemical Solutions, and Titanium Technologies. The Fluoroproducts segment offers fluorochemicals, including refrigerants, foam blowing agents, and propellants under the Freon and Opteon brand names; fluoropolymers, such as industrial resins, specialty products, and coatings under the Teflon, Viton, Krytox, and Nafion brands; and fluoroelastomer products un... [Read more...]
| Industry Specialty Chemicals | Founded 2014 |
| CEO Mark Vergnano | Employees 7,000 |
| Stock Exchange NYSE | Ticker Symbol CC |
Analyst Forecasts
According to 11 analysts, the average rating for CC stock is "Hold." The 12-month stock price forecast is 28.00, which is an increase of 4.52% from the latest price.